Marton Horvath
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marton Horvath has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Anders Malmström
Department of Experimental Medical Science, Lund University, Lund, Sweden
1 shared publication- Anna Bång-Rudenstam
Lund University
1 shared publication - Axel Boukredine
Lund University
1 shared publication - Chaitali Chakraborty
Department of Medical and Translational Biology, Section of Molecular Medicine, Umeå University, Umeå, Sweden
1 shared publication - Emil Tykesson
Department of Experimental Medical Science, Lund University, Lund, Sweden
1 shared publication - Emma Gustafsson
Lund University
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 11 February 2026
- Published by Springer Nature in Nature Cell Biology
- Vol. 28 (3) , 567-580
Tumour acidosis remodels the glycocalyx to control lipid scavenging and ferroptosis
Aggressive tumours are defined by microenvironmental stress adaptation and metabolic reprogramming. Within this niche, lipid droplet accumulation has emerged as a key strategy to buffer toxic lipids and suppress ferroptosis. Lipid droplet formation can occur via de novo lipogenesis or extracellular lipid-scavenging. However, how tumour cells coordinate these processes remains poorly understood. Here we identify a chondroitin sulfate (CS)-enriched glycocalyx as a hallmark of the acidic microenvironment in glioblastoma and central nervous system metastases. This CS-rich glycocalyx encapsulates tumour cells, limits lipid particle uptake and protects against lipid-induced ferroptosis. Mechanistically, we demonstrate that converging hypoxia-inducible factor and transforming growth factor beta signalling induces a glycan switch on syndecan-1—replacing heparan sulfate with CS—thereby impairing its lipid-scavenging function. Dual inhibition of CS biosynthesis and diacylglycerol O -acyltransferase-1, a critical enzyme in lipid droplet formation, triggers catastrophic lipid peroxidation and ferroptotic cell death. These findings define glycan remodelling as a core determinant of metabolic plasticity, positioning the dynamic glycocalyx as a master regulator of nutrient access, ferroptotic sensitivity and therapeutic vulnerability in cancer.
- 11 February 2026
- Published by Springer Nature in Nature Cell Biology
- Vol. 28 (3) , 567-580
Top Cited PapersOpen AccessTumour acidosis remodels the glycocalyx to control lipid scavenging and ferroptosis
Aggressive tumours are defined by microenvironmental stress adaptation and metabolic reprogramming. Within this niche, lipid droplet accumulation has emerged as a key strategy to buffer toxic lipids and suppress ferroptosis. Lipid droplet formation can occur via de novo lipogenesis or extracellular lipid-scavenging. However, how tumour cells coordinate these processes remains poorly understood. Here we identify a chondroitin sulfate (CS)-enriched glycocalyx as a hallmark of the acidic microenvironment in glioblastoma and central nervous system metastases. This CS-rich glycocalyx encapsulates tumour cells, limits lipid particle uptake and protects against lipid-induced ferroptosis. Mechanistically, we demonstrate that converging hypoxia-inducible factor and transforming growth factor beta signalling induces a glycan switch on syndecan-1—replacing heparan sulfate with CS—thereby impairing its lipid-scavenging function. Dual inhibition of CS biosynthesis and diacylglycerol O -acyltransferase-1, a critical enzyme in lipid droplet formation, triggers catastrophic lipid peroxidation and ferroptotic cell death. These findings define glycan remodelling as a core determinant of metabolic plasticity, positioning the dynamic glycocalyx as a master regulator of nutrient access, ferroptotic sensitivity and therapeutic vulnerability in cancer.